Surface NK receptors and their ligands on tumor cells

被引:230
作者
Moretta, Lorenzo
Bottino, Christina
Pende, Daniela
Castriconi, Roberta
Mingari, Maria Cristina
Moretta, Alessandro
机构
[1] Ist Giannina Gaslini, I-16148 Genoa, Italy
[2] Univ Genoa, Dipartimento Med Sperimentale, I-16132 Genoa, Italy
[3] Univ Genoa, Ctr Eccellenza Ric Biomed, Genoa, Italy
[4] Ist Nazl Ric Canc, I-16132 Genoa, Italy
[5] Univ Genoa, Dipartimento Oncol Biol & Genet, I-16132 Genoa, Italy
关键词
natural killer cells; cytolytic T lymphocytes; killer Ig-like receptors; HLA-class I molecules; inhibitory receptors; activating receptors; KIR repertoire;
D O I
10.1016/j.smim.2006.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The identification of MHC-class I-specific inhibitory receptors in humans and mice provided a first explanation of why NK cells can kill target cells that have lost or underexpress MHC-class I molecules but spare normal cells. However, the molecular basis of NK-mediated recognition and tumor cell killing revealed a higher degree of complexity. Thus, under pathological conditions, NK cells may express insufficient amounts of triggering receptors and target cells may or may not express ligands for such receptors. Here we briefly illustrate the main NK receptors and their cellular ligands and we delineate the major receptor/ligands interactions leading to NK cell activation and tumor cell lysis. (C) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 108 条
[1]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
IMMUNOLOGY TODAY, 2000, 21 (09) :447-455
[2]   The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules:: implications for tumor immune escape [J].
Algarra, I ;
García-Lora, A ;
Cabrera, T ;
Ruiz-Cabello, F ;
Garrido, F .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2004, 53 (10) :904-910
[3]   Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors [J].
André, P ;
Castriconi, R ;
Espéli, M ;
Anfossi, N ;
Juarez, T ;
Hue, S ;
Conway, H ;
Romagné, F ;
Dondero, A ;
Nanni, M ;
Caillat-Zucman, S ;
Raulet, DH ;
Bottino, C ;
Vivier, E ;
Moretta, A ;
Paul, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (04) :961-971
[4]   The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 [J].
Arnon, TI ;
Achdout, H ;
Lieberman, N ;
Gazit, R ;
Gonen-Gross, T ;
Katz, G ;
Bar-Ilan, A ;
Bloushtain, N ;
Lev, M ;
Joseph, A ;
Kedar, E ;
Porgador, A ;
Mandelboim, O .
BLOOD, 2004, 103 (02) :664-672
[5]  
Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO
[6]  
2-A
[7]   The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast [J].
Bachelet, I ;
Munitz, A ;
Moretta, A ;
Moretta, L ;
Levi-Schaffer, F .
JOURNAL OF IMMUNOLOGY, 2005, 175 (12) :7989-7995
[8]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[9]  
Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO
[10]  
2-O